Table 4.
Author, y | Domain | Effect size, d | 95% confidence interval |
---|---|---|---|
Sickle cell disease | |||
PedsQL | |||
Bhatia et al,55 2015 | Physical | 0.97 | (0.22-1.71)* |
Social | 0.77 | (0.04-1.48)* | |
Emotional | 1.02 | (0.28-1.76)* | |
Psychosocial | 1.01 | (0.27-1.75)* | |
Overall | 1.10 | (0.34-1.84)* | |
Thalassemia | |||
PedsQL | |||
Caocci et al,44 2011 | Physical | 0.86 | (0.31-1.4)* |
Social | 1.06 | (0.5-1.62)* | |
Emotional | 0.27 | (-0.25 to 0.8) | |
Psychosocial | 1.25 | (0.67-1.82)* | |
Overall | 2.05 | (1.39-2.69)* | |
Cheuk et al,47 2008 | Physical | 0.41 | (-0.24 to 1.05) |
Social | 0.16 | (-0.49 to 0.8) | |
Emotional | 0.33 | (-0.32 to 0.97) | |
Psychosocial | 0.17 | (-0.48 to 0.81) | |
School | −0.08 | (-0.72 to 0.56) | |
Overall | 0.21 | (0.22-0.18)* | |
Patel et al,51 2018 | Physical | 0.78 | (0.32-1.23)* |
Social | 0.26 | (-0.18 to 0.7) | |
Emotional | 0.72 | (0.26-1.17)* | |
Psychosocial | 0.80 | (0.34-1.26)* | |
School | 0.86 | (0.4-1.31)* | |
Overall | 0.69 | (0.24-1.14)* | |
Uygun et al,52 2012 | Physical | 1.07 | (0.56-1.57)* |
Social | 0.53 | (0.05-1.01)* | |
Emotional | 0.78 | (0.29-1.26)* | |
School | 0.63 | (0.15-1.11)* | |
Psychosocial | 0.55 | (0.07-1.02)* | |
Overall | 0.71 | (0.23-1.19)* | |
SF-36 | |||
Caocci et al,46 2016 (Thalassemia control) | Physical Component Score | 0.82 | (0.48-1.16)* |
Mental Component Score | 0.57 | (0.23-0.9)* | |
Caocci et al,46 2016 (Sibling control) | Physical Component Score | −0.27 | (-0.6 to 0.06) |
Mental Component Score | 0.40 | (0.06-0.73)* | |
Javanbakht et al,48 2015 | Physical | 0.50 | (0.16-0.84)* |
Role Physical | 0.52 | (0.18-0.86)* | |
Bodily Pain | −0.02 | (-0.35 to 0.32) | |
General Health | 0.19 | (-0.14 to 0.53) | |
Vitality | 0.22 | (-0.11 to 0.56) | |
Social Functioning | 0.33 | (-0.01 to 0.66) | |
Role Emotional | 0.57 | (0.23-0.91)* | |
Mental Health | 0.26 | (-0.08 to 0.6) | |
La Nasa et al,50 2013 (Transfusion control) | Physical | 0.17 | (-0.09 to 0.43) |
Role Physical | 0.88 | (0.61-1.15)* | |
Bodily Pain | 0.82 | (0.56-1.09)* | |
General Health | 0.20 | (-0.06 to 0.46) | |
Vitality | 0.28 | (0.02-0.54)* | |
Social Functioning | −0.04 | (-0.3 to 0.21) | |
Role Emotional | 0.63 | (0.37-0.9)* | |
Mental Health | 0.18 | (-0.08 to 0.43) | |
La Nasa et al,50 2013 (Matched general population control) | Physical | 0.05 | (-0.22 to 0.31) |
Role Physical | 0.29 | (0.02-0.55)* | |
Bodily Pain | 0.23 | (-0.04 to 0.49) | |
General Health | −0.11 | (-0.37 to 0.16) | |
Vitality | 0.13 | (-0.14 to 0.4) | |
Social Functioning | 0.20 | (-0.07 to 0.47) | |
Role Emotional | 0.39 | (0.12-0.65)* | |
Mental health | 0.41 | (0.14-0.68)* | |
WHOQoL-BREF | |||
Cheuk et al,47 2008 | Physical | 0.79 | (0.21-1.35)* |
Global | 0.26 | (-0.3 to 0.82) | |
Cultural adjusted | 0.22 | (-0.34 to 0.78) | |
Social Relationships | 0.36 | (-0.2 to 0.92) | |
Environment | 0.06 | (-0.5 to 0.61) | |
Uygun et al,52 2012 | Physical | 0.91 | (-0.01 to 1.81) |
Psychological | 0.22 | (-0.65 to 1.09) | |
Social Relationships | 1.24 | (0.27-2.17)* | |
Environment | 0.34 | (-0.53 to 1.21) |
Indicates an effect size with statistically significant improvement in a quality-of-life domain following hematopoietic stem cell transplant (<0.05).